Federal Register / Vol. 87, No. 115 / Wednesday, June 15, 2022 / Notices 36133 

Dated: June 9, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–12837 Filed 6–14–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund India 

Council of Medical Research (IMCR) 

and ICMR Institutions: National 

Institute of Virology (NIV), Pune and 

National Institute of Epidemiology 

(NIE), Chennai 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces 

three (3) separate awards within the 

government of India to include the 

Indian Council of Medical Research 

(ICMR) New Delhi, National Institute of 

Virology (NIV) and National Institute of 

Epidemiology (NIE). For ICMR New 

Delhi, the award is for approximately 

$8,165,0000 with an expected total 

funding of approximately $24,495,000. 

For NIV, the award is for approximately 

$8,165,0000 with an expected total 

funding of approximately $24,495,000. 

For NIE, the award is for approximately 

$8,165,0000 with an expected total 

funding of approximately $24,495,000. 

The total 5-year period amount for the 

three recipients is $122,475,000. The 

awards will accelerate progress toward 

an India safe and secure from infectious 

disease threats through ICMR 

institutions’ focus on emerging and reemerging pathogens, including 

detecting, and controlling zoonotic 

disease outbreaks through a One Health 

approach; evaluating vaccine safety 

monitoring systems; capacitating the 

public health workforce in field 

epidemiology and outbreak response; 

and combating antimicrobial resistance. 

DATES: The period for these awards will 

be September 30, 2022, through 

September 29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Shana Eatman, Centers for Disease 

Control and Prevention, 1825 Century 

Center, MS V18–3, Atlanta, GA 30345, 

Telephone: 770–488–3933, E-Mail: 

DGHPNOFOs@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source awards will continue 

support to strengthening cooperation 

with and capacity of the India Council 

of Medical Research (ICMR) institutions 

to prevent avoidable epidemics, early 

detection of disease threats, and rapid 

and effective response. 

India Council of Medical Research is 

in a unique position to conduct this 

work, as it was originally established as 

an apex body for the formulation, 

coordination, and promotion of 

biomedical research in India, and has 

taken up most of the laboratory-based 

surveillance of infectious diseases in 

recent years. Eligibility for funding is 

limited to the ICMR, New Delhi and 

ICMR institutions including the 

National Institute of Virology (NIV), 

Pune and the National Institute of 

Epidemiology (NIE), Chennai. ICMR is 

the apex governing body for the 

numerous national level institutes 

which are centres for excellence and 

reference in specific scientific area for 

India, namely National Institute of 

Virology, National Institute of 

Epidemiology, and several others. These 

institutions are mandated by the 

Ministry of Health of Family Health and 

Welfare (MoHFW) to provide oversight 

for laboratory confirmation of priority 

pathogens in India in a tiered manner as 

well as collate and analyze surveillance 

data for public health actions and work 

closely with the state governments 

where these institutes are located. 

Summary of the Award 

Recipient: India Council of Medical 

Research (IMCR), New Delhi and ICMR 

institutions: National Institute of 

Virology (NIV), Pune and National 

Institute of Epidemiology (NIE), 

Chennai. 

Purpose of the Award: The purpose of 

these awards is to accelerate progress 

toward an India safe and secure from 

infectious disease threats through ICMR 

institutions’ focus on emerging and reemerging pathogens, including 

detecting, and controlling zoonotic 

disease outbreaks through a One Health 

approach; evaluating vaccine safety 

monitoring systems; capacitating the 

public health workforce in field 

epidemiology and outbreak response; 

and combating antimicrobial resistance. 

These GHS strategies will result in 

outcomes that will strengthen the Indian 

public health system; decrease 

morbidity and mortality; and improve 

pandemic and epidemic preparedness 

and response. 

Amount of Award: $8,165,000 in 

Federal Fiscal Year (FFY) 2022 funds 

per institution, with a total estimated 

$122,475,0000 for the 5-year period of 

performance, subject to availability of 

funds. Please note, the NOFO funding 

strategy is as follows: $660,000 for Core 

Component 1, and $7,505,000 in 

Approved but Unfunded (ABU) 

Components for each recipient. 

Authority: This program is authorized 

under Section 307 of the Public Health 

Service Act [42 U.S.C. 242I] and Section 

301(a) [42 U.S.C. 241(a)] of the Public 

Health Service Act. 

Period of Performance: September 30, 

2022, through September 29, 2027. 

Dated: June 9, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–12850 Filed 6–14–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Public Health Service Act (PHS), 

Delegation of Authority 

Notice is hereby given that I have 

delegated to the Director, National 

Institute for Occupational Safety and 

Health, Centers for Disease Control and 

Prevention (CDC), without authority to 

redelegate, all authorities vested in the 

Secretary, under Sections 2695G–2695I, 

Title XXVI of the PHS Act (42 U.S.C. 

300ff–138–300ff–140), as amended. This 

may not be redelegated. 

This delegation is effective upon date 

of signature. In addition, I hereby affirm 

and ratify any actions taken by you or 

your subordinates which involved the 

exercise of the authorities delegated 

herein prior to the effective date of this 

delegation. 

Dated: June 8, 2022. 

Xavier Becerra, 

Secretary. 

[FR Doc. 2022–12835 Filed 6–14–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2013–N–0013] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Sanitary 

Transportation of Human and Animal 

Food 

AGENCY: Food and Drug Administration, 

HHS. 


jspears on DSK121TN23PROD with NOTICES1